See the DrugPatentWatch profile for vascepa

The enrollment for Vascepa, a prescription medication used to treat high triglyceride levels, is set to expire on April 25, 2029, as per the FDA approval document for Vascepa [3]. This expiration date indicates when the enrollment for the drug will no longer be active. For more detailed information on Vascepa, its uses, and enrollment, you can refer to the official Vascepa website [2]. Additionally, for updates on the patent status of Vascepa, you can consult Drug Patent Watch [1].

Sources:
[1] drugpatentwatch.com/p/tradename/VASCEPA
[2] vascepa.com
[3] accessdata.fda.gov/drugsatfda_docs/nda/2012/202057orig1s000approv.pdf